Loading...
XHKG
3332
Market cap54mUSD
Apr 11, Last price  
0.45HKD
1D
3.45%
1Q
-30.77%
Jan 2017
-73.05%
IPO
-83.33%
Name

Nanjing Sinolife United Co Ltd

Chart & Performance

D1W1MN
P/E
7.61
P/S
0.71
EPS
0.06
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
4.47%
Revenues
748m
+32.62%
150,372,000194,736,000252,449,000397,064,000466,241,000472,490,000453,199,000322,613,000296,525,000252,325,000274,851,000563,959,000747,898,000
Net income
35m
-34.30%
57,237,00070,786,000107,873,000136,233,00087,232,0004,209,000-112,837,000-194,658,000-49,605,000-31,707,000-14,246,00052,602,00034,562,000
CFO
0k
-100.00%
57,923,00082,076,00087,649,000104,658,00077,712,000-108,740,00030,577,000-68,136,00016,408,000421,0007,915,00047,109,0000
Dividend
Jul 06, 20170.0457 HKD/sh
Earnings
Jun 06, 2025

Profile

Nanjing Sinolife United Company Limited, an investment holding company, engages in the manufacture, processing, and sale of nutritional supplements in the People's Republic of China, Australia, New Zealand, Vietnam, and internationally. The company is also manufactures and sale of cosmetics and skin care products; and trading, retail, and testing of packaged health food products. It sells its products under the Good Health, Zhongsheng, Hejian, and Cobayer series through a network of retail stores. The company also sells its products through distributors, TV shopping, and e-commerce platforms; and chain pharmacies, health goods supermarkets, and tourist souvenir shops. Nanjing Sinolife United Company Limited was incorporated in 1999 and is headquartered in Nanjing, China.
URL
http://www.zs-united.com/
IPO date
Jan 15, 2014
Employees
319
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
747,898
32.62%
563,959
105.19%
274,851
8.93%
Cost of revenue
707,778
507,353
288,219
Unusual Expense (Income)
NOPBT
40,120
56,606
(13,368)
NOPBT Margin
5.36%
10.04%
Operating Taxes
6,320
5,491
3,746
Tax Rate
15.75%
9.70%
NOPAT
33,800
51,115
(17,114)
Net income
34,562
-34.30%
52,602
-469.24%
(14,246)
-55.07%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
4,286
4,143
4,368
Long-term debt
63,516
66,183
67,138
Deferred revenue
Other long-term liabilities
12,707
14,279
774
Net debt
(36,728)
(52,468)
(1,885)
Cash flow
Cash from operating activities
47,109
7,915
CAPEX
(2,345)
(3,864)
Cash from investing activities
449
(3,467)
Cash from financing activities
(4,498)
(4,078)
FCF
(8,724)
36,595
(32,787)
Balance
Cash
104,530
122,794
73,391
Long term investments
Excess cash
67,135
94,596
59,648
Stockholders' equity
394,096
(112,665)
(276,325)
Invested Capital
373,569
540,176
635,243
ROIC
7.40%
8.70%
ROCE
9.10%
13.24%
EV
Common stock shares outstanding
946,298
946,298
946,298
Price
0.54
134.78%
0.23
94.92%
0.12
-24.84%
Market cap
511,001
134.78%
217,649
94.92%
111,663
-24.84%
EV
474,273
221,083
109,778
EBITDA
40,120
70,317
1,541
EV/EBITDA
11.82
3.14
71.24
Interest
3,280
472
Interest/NOPBT
5.79%